Lobbying Relationship

Client

Summit Therapeutics plc

Biopharmaceutical company; develops medicines to treat infectious diseases More records

Lobbying firm

THE KPM GROUP DC LLC

Lobbying Firm More records

  • COVID -19 Stimulus Package (domestic manufacturing)

Duration: to

May Have Ended?

General Issues: Pharmacy

Related Foreign Entities: Summit Therapeutics Plc (Abingdon, Oxfordshire, GBR); contribution to lobbying: $30000; ownership 100%

Lobbyists

Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.

Lobbyist Covered positions?
Benjamin Mason Communications Director; Rep. David Young January 2017 - June 2017
Patroski Lawson n/a

Disclosures Filed

Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.

This representation may have ended. No reports have been filed in the past 160 days, though termination paperwork has not been released.

Registration

Source: Clerk of the U.S. House of Representatives and Secretary of the Senate

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page